MedTrace Logo

The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site

NCT01761136 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2013-03-28

No results posted yet for this study

Summary

The objective of this study was to evaluate the safety and immunogenicity of Haemophilus influenzae type b vaccine in different injection site.

Conditions

  • Healthy

Interventions

BIOLOGICAL

Inoculation in upper arm deltoid

Inoculation of Hib vaccine of two brands in upper arm deltoid

BIOLOGICAL

Inoculation in vastus lateralis muscle

Inoculation of Hib vaccine of two brands in vastus lateralis muscle

Sponsors & Collaborators

  • Beijing Center for Disease Control and Prevention

    lead OTHER_GOV

Principal Investigators

  • Nianmin Shi · Beijing Chaoyang District Center for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01761136 on ClinicalTrials.gov